MAG
MRK icon

Meadowbrook Advisors Group’s Merck MRK Stock Holding History

Meadowbrook Advisors Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$974K Sell
7,576
-2,850
-27% -$334K 0.52% 60
2026
Q1 		$1.25M Sell
10,426
-1,110
-10% -$128K 0.75% 47
2025
Q4 		$1.21M Buy
+11,536
New +$1.08M 0.68% 51

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Meadowbrook Advisors Group's MRK Position: Q2 2026 in Review

Meadowbrook Advisors Group reduced its Merck (MRK) stake by 27% in Q2 2026, selling an estimated $334K and leaving 7,576 shares worth $974K. The position accounts for 0.52% of the portfolio, ranked #60.

Meadowbrook Advisors Group first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.25M in Q1 2026. 3,817 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Meadowbrook Advisors Group held 7,576 shares of Merck worth $974K as of Q2 2026.
  • Meadowbrook Advisors Group sold 2,850 Merck shares in Q2 2026, an estimated $334K.
  • Merck made up 0.52% of Meadowbrook Advisors Group's portfolio in Q2 2026, its #60 holding.
  • Meadowbrook Advisors Group first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • Meadowbrook Advisors Group's Merck position peaked at $1.25M in Q1 2026.
  • 3,817 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Meadowbrook Advisors Group's 13F filing for Q2 2026, filed 7 Aug 2026.